Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

ISOLATION AND CHARACTERIZATION OF cDNA OF PLASMODIUM FALCIPARUM GLUCOSE-6-PHOSPHATE DEHYDROGENASE

  • Read more about ISOLATION AND CHARACTERIZATION OF cDNA OF PLASMODIUM FALCIPARUM GLUCOSE-6-PHOSPHATE DEHYDROGENASE
US Application 07/762,137
Filed on 1991-09-20

GLUCURONOXYLOMANNAN-PROTEIN CONJUGATES OF CRYPTOCOCCUS NEOFORMANS

  • Read more about GLUCURONOXYLOMANNAN-PROTEIN CONJUGATES OF CRYPTOCOCCUS NEOFORMANS
US Application 07/760,143
Filed on 1991-09-16

CHIMERIC DENGUE VIRUSES

  • Read more about CHIMERIC DENGUE VIRUSES
US Application 07/761,222
Filed on 1991-09-19

Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

  • Read more about Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4
Patent Cooperation Treaty
PCT/US2003/013279
Filed on 2003-04-25

CLONING OF CDNA ENCODING A FUNCTIONAL HUMAN INTERLEUKIN-8 RECEPTOR

  • Read more about CLONING OF CDNA ENCODING A FUNCTIONAL HUMAN INTERLEUKIN-8 RECEPTOR
US Patent 5,374,506
Filed on 1991-09-13

VACUUM FILTRATION IMPROVEMENT

  • Read more about VACUUM FILTRATION IMPROVEMENT
US Patent 5,236,584
Filed on 1991-09-06

ADENO-ASSOCIATED VIRUS (AAV)-BASED EUCARYOTIC VECTORS

  • Read more about ADENO-ASSOCIATED VIRUS (AAV)-BASED EUCARYOTIC VECTORS
US Application 07/752,899
Filed on 1991-08-26

INTERLEUKIN-2 STIMULATED T LYMPHOCYTE CELL DEATH FOR THE TREATMENT OF AUTOIMMUNE DISEASES, ALLERGIC DISORDERS, AND GRAFT REJECTION

  • Read more about INTERLEUKIN-2 STIMULATED T LYMPHOCYTE CELL DEATH FOR THE TREATMENT OF AUTOIMMUNE DISEASES, ALLERGIC DISORDERS, AND GRAFT REJECTION
US Application 07/751,090
Filed on 1991-08-28

C-TERMINALLY TRUNCATED DENGUE AND JAPANESE ENCEPHALITIS VIRUS ENVELOPE PROTEINS

  • Read more about C-TERMINALLY TRUNCATED DENGUE AND JAPANESE ENCEPHALITIS VIRUS ENVELOPE PROTEINS
US Patent 5,494,671
Filed on 1991-08-20

AMINO ACID DERIVATIVE AND BROMOACETYL MODIFIED PEPTIDES FOR THE PREPARATION OF SYNTHETIC PEPTIDE POLYMERS, CONJUGATED...

  • Read more about AMINO ACID DERIVATIVE AND BROMOACETYL MODIFIED PEPTIDES FOR THE PREPARATION OF SYNTHETIC PEPTIDE POLYMERS, CONJUGATED...
US Patent 5,286,846
Filed on 1991-06-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 577
  • Page 578
  • Page 579
  • Page 580
  • Page 581
  • Page 582
  • Page 583
  • Page 584
  • Page 585
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health